Author： Mehr Ian J
Publisher： Future Medicine
ISSN： 1462-2416
Source： Pharmacogenomics, Vol.1, Iss.1, 2000-02, pp. : 1-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
Implications of the incidentalome for clinical pharmacogenomics
By Brothers Kyle B Langanke Martin Erdmann Pia
Pharmacogenomics, Vol. 14, Iss. 11, 2013-08 ,pp. :
Access to resources
Recommend
Pharmacogenomics and Clinical R&D
By Arnold Hans Peter Hall Susan T
Pharmacogenomics, Vol. 6, Iss. 8, 2005-12 ,pp. :
Pharmacogenomics—Clinical and Social Implications
JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol. 33, Iss. 3, 2003-09 ,pp. :
Clinical Pharmacogenomics of Thiopurine S-methyltransferase
Current Clinical Pharmacology, Vol. 1, Iss. 1, 2006-01 ,pp. :
Ethical considerations in clinical pharmacogenomics research
By Issa A.M.
Trends in Pharmacological Sciences, Vol. 21, Iss. 7, 2000-07 ,pp. :